1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Voice of Customer
5.
Global Active Pharmaceutical Ingredient Market Outlook
5.1.
Market Size & Forecast
5.1.1.
By Value
5.2.
Market Share & Forecast
5.2.1. By Type of Synthesis
(Biotech (Recombinant Proteins, Vaccines, Monoclonal Antibodies), Fermentation,
Plant Extracts, Synthetic)
5.2.2. By Type of
Manufacturer (In-house, Contract)
5.2.3. By Route of
Administration (Oral, Injectable, Topical)
5.2.4. By Type of Drug (Innovative,
Generic)
5.2.5. By Therapeutic
Application (Cardiovascular Disease, Oncology, Neurological Disorders,
Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology, Others)
5.2.6. By Company (2022)
5.2.7. By
Region
6.
North America Active Pharmaceutical Ingredient Market
Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1. By Type of Synthesis
6.2.2. By Type of
Manufacturer
6.2.3. By Route of
Administration
6.2.4. By Type of Drug
6.2.5. By Therapeutic
Application
6.2.6.
By Country
6.3.
North America: Country Analysis
6.3.1.
United States Active Pharmaceutical Ingredient Market
Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Type of Synthesis
6.3.1.2.2.
By Type of Manufacturer
6.3.1.2.3.
By Route of Administration
6.3.1.2.4.
By Type of Drug
6.3.1.2.5.
By Therapeutic Application
6.3.2.
Mexico Active Pharmaceutical Ingredient Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Type of Synthesis
6.3.2.2.2.
By Type of Manufacturer
6.3.2.2.3.
By Route of Administration
6.3.2.2.4.
By Type of Drug
6.3.2.2.5.
By Therapeutic Application
6.3.3.
Canada Active Pharmaceutical Ingredient Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Type of Synthesis
6.3.3.2.2.
By Type of Manufacturer
6.3.3.2.3.
By Route of Administration
6.3.3.2.4.
By Type of Drug
6.3.3.2.5.
By Therapeutic Application
7.
Europe Active Pharmaceutical Ingredient Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1. By Type of Synthesis
7.2.2. By Type of
Manufacturer
7.2.3. By Route of
Administration
7.2.4. By Type of Drug
7.2.5. By Therapeutic
Application
7.2.6.
By Country
7.3.
Europe: Country Analysis
7.3.1.
France Active Pharmaceutical Ingredient Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type of Synthesis
7.3.1.2.2.
By Type of Manufacturer
7.3.1.2.3.
By Route of Administration
7.3.1.2.4.
By Type of Drug
7.3.1.2.5.
By Therapeutic Application
7.3.2.
Germany Active Pharmaceutical Ingredient Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type of Synthesis
7.3.2.2.2.
By Type of Manufacturer
7.3.2.2.3.
By Route of Administration
7.3.2.2.4.
By Type of Drug
7.3.2.2.5.
By Therapeutic Application
7.3.3.
United Kingdom Active Pharmaceutical Ingredient Market
Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type of Synthesis
7.3.3.2.2.
By Type of Manufacturer
7.3.3.2.3.
By Route of Administration
7.3.3.2.4.
By Type of Drug
7.3.3.2.5.
By Therapeutic Application
7.3.4.
Italy Active Pharmaceutical Ingredient Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Type of Synthesis
7.3.4.2.2.
By Type of Manufacturer
7.3.4.2.3.
By Route of Administration
7.3.4.2.4.
By Type of Drug
7.3.4.2.5.
By Therapeutic Application
7.3.5.
Spain Active Pharmaceutical Ingredient Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Type of Synthesis
7.3.5.2.2.
By Type of Manufacturer
7.3.5.2.3.
By Route of Administration
7.3.5.2.4.
By Type of Drug
7.3.5.2.5.
By Therapeutic Application
8.
Asia-Pacific Active Pharmaceutical Ingredient Market
Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1. By Type of Synthesis
8.2.2. By Type of
Manufacturer
8.2.3. By Route of
Administration
8.2.4. By Type of Drug
8.2.5. By Therapeutic
Application
8.2.6.
By Country
8.3.
Asia-Pacific: Country Analysis
8.3.1.
China Active Pharmaceutical Ingredient Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type of Synthesis
8.3.1.2.2.
By Type of Manufacturer
8.3.1.2.3.
By Route of Administration
8.3.1.2.4.
By Type of Drug
8.3.1.2.5.
By Therapeutic Application
8.3.2.
India Active Pharmaceutical Ingredient Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type of Synthesis
8.3.2.2.2.
By Type of Manufacturer
8.3.2.2.3.
By Route of Administration
8.3.2.2.4.
By Type of Drug
8.3.2.2.5.
By Therapeutic Application
8.3.3.
Japan Active Pharmaceutical Ingredient Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type of Synthesis
8.3.3.2.2.
By Type of Manufacturer
8.3.3.2.3.
By Route of Administration
8.3.3.2.4.
By Type of Drug
8.3.3.2.5.
By Therapeutic Application
8.3.4.
South Korea Active Pharmaceutical Ingredient Market
Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Type of Synthesis
8.3.4.2.2.
By Type of Manufacturer
8.3.4.2.3.
By Route of Administration
8.3.4.2.4.
By Type of Drug
8.3.4.2.5.
By Therapeutic Application
8.3.5.
Australia Active Pharmaceutical Ingredient Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Type of Synthesis
8.3.5.2.2.
By Type of Manufacturer
8.3.5.2.3.
By Route of Administration
8.3.5.2.4.
By Type of Drug
8.3.5.2.5.
By Therapeutic Application
9.
South America Active Pharmaceutical Ingredient Market
Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1. By Type of Synthesis
9.2.2. By Type of
Manufacturer
9.2.3. By Route of Administration
9.2.4. By Type of Drug
9.2.5. By Therapeutic
Application
9.2.6.
By Country
9.3.
South America: Country Analysis
9.3.1.
Brazil Active Pharmaceutical Ingredient Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type of Synthesis
9.3.1.2.2.
By Type of Manufacturer
9.3.1.2.3.
By Route of Administration
9.3.1.2.4.
By Type of Drug
9.3.1.2.5.
By Therapeutic Application
9.3.2.
Argentina Active Pharmaceutical Ingredient Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type of Synthesis
9.3.2.2.2.
By Type of Manufacturer
9.3.2.2.3.
By Route of Administration
9.3.2.2.4.
By Type of Drug
9.3.2.2.5.
By Therapeutic Application
9.3.3.
Colombia Active Pharmaceutical Ingredient Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type of Synthesis
9.3.3.2.2.
By Type of Manufacturer
9.3.3.2.3.
By Route of Administration
9.3.3.2.4.
By Type of Drug
9.3.3.2.5.
By Therapeutic Application
10.
Middle East and Africa Active Pharmaceutical Ingredient
Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1. By Type of Synthesis
10.2.2. By Type of
Manufacturer
10.2.3. By Route of
Administration
10.2.4. By Type of Drug
10.2.5. By Therapeutic
Application
10.2.6.
By Country
10.3.
MEA: Country Analysis
10.3.1.
South Africa Active Pharmaceutical Ingredient Market
Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Type of Synthesis
10.3.1.2.2.
By Type of Manufacturer
10.3.1.2.3.
By Route of Administration
10.3.1.2.4.
By Type of Drug
10.3.1.2.5.
By Therapeutic Application
10.3.2.
Saudi Arabia Active Pharmaceutical Ingredient Market
Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Type of Synthesis
10.3.2.2.2.
By Type of Manufacturer
10.3.2.2.3.
By Route of Administration
10.3.2.2.4.
By Type of Drug
10.3.2.2.5.
By Therapeutic Application
10.3.3.
UAE Active Pharmaceutical Ingredient Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Type of Synthesis
10.3.3.2.2.
By Type of Manufacturer
10.3.3.2.3.
By Route of Administration
10.3.3.2.4.
By Type of Drug
10.3.3.2.5.
By Therapeutic Application
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
13.
Competitive Landscape
13.1.
Competition Outlook
13.2.
Players Profiled (Leading Companies)
13.2.1.
Teva Pharmaceutical
Industries Ltd.
13.2.2.
Bristol-Myers Squibb
Company
13.2.3.
Boehringer Ingelheim
GmbH
13.2.4.
Merck & Co.,
Inc.
13.2.5.
GlaxoSmithKline Plc
13.2.6.
Novartis International
AG
13.2.7.
F. Hoffmann-La Roche
AG
13.2.8.
Sanofi S.A.
13.2.9.
Eli Lilly and
Company
13.2.10.
AbbVie Inc
Strategic Recommendations